Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $25,084,877 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 163 grants at over 100 hospitals in 29 countries.
UNC Eshelman School of Pharmacy – $50,000
$50,000.00
December 2024
Leveraging Open Science and Collaboration to Identify Clinical Quality ALK2 Inhibitors for DIPG
Murdoch Children's Research Institute – $100,000 USD / $156,914 AUD
$100,000.00
December 2024
Harnessing Developmental Neurobiology to Reprogram the Cell of Origin of Diffuse Midline Gliomas
Children's Healthcare of Atlanta – $100,000
$100,000.00
November 2024
Radiation Resistance in Medulloblastoma
University of Texas Health Science Center at San Antonio – $100,000
$100,000.00
November 2024
Targeting Metabolic Vulnerabilities for Treating Medulloblastoma
University of Texas Health Science Center at San Antonio – $50,000
$50,000.00
November 2024
Targeting RRNA Modification and SNORNA Function, A Novel Concept to Treat Aggressive Medulloblastoma
Children’s National Medical Center – $300,000
$300,000.00
November 2024
Multilamellar H3K27M RNA aggregates targeting diffuse midline glioma, including diffuse intrinsic pontine glioma.
Children's Hospital Los Angeles – $100,000
$100,000.00
October 2024
Targeting FOXR2 in Diffuse Midline Gliomas
University Hospital of Navarra - $100,000 USD, €92,637 EUR
$100,000.00
October 2024
Targeting Diffuse Midline Glioma vulnerabilities as a therapeutic strategy.
The Institute of Cancer Research – $111,445 USD / £85,976 GBP
$111,445.00
October 2024
Unravelling transcriptional plasticity as a non-genetic mechanism of drug resistance in DMG.
Children’s Cancer Institute – $100,000 USD / $150,589 AUD
$100,000.00
October 2024
Targeting lactate production pathways as a novel therapy against DIPG
Sydney Children's Hospital - Randwick – $196,577 USD / $296,025.11 AUD
$196,577.00
October 2024
Unlocking the potential of the blood-brain barrier in the fight against paediatric brain gliomas.
McGill University - $100,000
$100,000.00
October 2024
Understanding tumor heterogeneity and characterizing treatment responses in ACVR1-mutated diffuse midline gliomas.
Cincinnati Children’s Hospital Medical Center - $200,000
$200,000.00
October 2024
Combining FLASH and immunotherapy to target medulloblastoma relapse
Emory University / Cincinnati Children's Hospital – $93,250
$93,250.00
March 2024
SUMOylation as a novel therapeutic target in DIPG
University of Chicago Medical Center / Washington University St. Louis – $100,000
$100,000.00
December 2023
Characterizing and Targeting ABL1 and ABL2 in Medulloblastoma Leptomeningeal Dissemination.